BlackRock
CORV

BlackRock’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

BlackRock’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-15,848
Closed -$6K – 5134
2019
Q4 		$6K Hold
15,848
– – ﹤0.01% 4786
2019
Q3 		$32K Hold
15,848
– – ﹤0.01% 4594
2019
Q2 		$34K Hold
15,848
– – ﹤0.01% 4632
2019
Q1 		$50K Hold
15,848
– – ﹤0.01% 4480
2018
Q4 		$39K Buy
+15,848
New +$52.8K ﹤0.01% 4509

Other funds holding CORV

BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $764M AUM 24.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

BlackRock's CORV Position: Q1 2020 in Review

BlackRock sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q1 2020, closing a stake of 15,848 shares — an estimated $6K sold.

BlackRock first reported a position in CORV in Q4 2018 and held it in 5 quarters. The position peaked at $50K in Q1 2019. 27 funds tracked by Wall St. Rank hold CORV as of Q1 2020.

  • BlackRock reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q1 2020 after selling out during the quarter.
  • BlackRock sold 15,848 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q1 2020, an estimated $6K.
  • BlackRock first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q4 2018 and held it in 5 quarters.
  • BlackRock's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $50K in Q1 2019.
  • 27 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q1 2020.

Based on BlackRock's 13F filing for Q1 2020, filed 1 May 2020.